Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Is lipitor linked to endurance decline?Can you name the year of keytruda's fda approval for cancer therapy?What is the cost of cosentyx with insurance?Can lipitor negate exercise's positive effects?Is there a link between acyclovir and increased organ damage risk over time?
See the DrugPatentWatch profile for wegovy
What other drugs might interact with Wegovy? Wegovy contains semaglutide and belongs to the class of medications known as GLP-1 receptor agonists. It works by mimicking a hormone that regulates appetite and blood sugar. Any medication that affects insulin levels, delayed gastric emptying, or oral absorption could interact with Wegovy. How does delayed gastric emptying affect other medications? Wegovy slows stomach emptying. This can delay the absorption of oral drugs taken at the same time, including antibiotics, pain relievers, and oral contraceptives. Patients taking narrow-therapeutic-index drugs such as warfarin or digoxin should consult a healthcare provider about possible timing adjustments. What happens if someone takes insulin or sulfonylureas with Wegovy? Wegovy itself does not require insulin. The risk of hypoglycemia increases when it is combined with insulin or sulfonylureas. Patients may need to reduce their insulin or sulfonylurea dose and monitor blood sugar closely. Can oral contraceptives still work when used with Wegovy? Delayed gastric emptying may affect the reliability of oral contraceptives. Patients who use oral pills should consider adding a barrier method for the first four weeks after starting Wegovy or after any dose increase. When does the Wegovy patent expire? The patent covering semaglutide is held by Novo Nordisk. It expires in 2032 in the United States. Biosimilar versions may appear after that date, but current data indicate no generic semaglutide for weight loss will be available sooner.
Other Questions About Wegovy :